Skip to main content

Lumos Pharma, Inc.

LUMODelisted Dec 12, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001126234

Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Lumos Pharma, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of LUMO: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders36129−6
Shares2.08M41.1K2.09M+51.3K (+2.5%)
Value$4.82M$95.4K$8.08M+$3.36M (+71.0%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Lumos Pharma, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to LUMO in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.39,825$154.1K0.00%
ADAR1 Capital Management, LLC10,000$38.7K0.01%
UBS Group AG6,557$25.4K0.00%

Sold out (9)

Institutions that held Lumos Pharma, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Lumos Pharma, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LUMO in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.41,104$95.4K